CHEBI:472552 - 5-bromo-2'-deoxyuridine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name 5-bromo-2'-deoxyuridine
Definition A pyrimidine 2'-deoxyribonucleoside compound having 5-bromouracil as the nucleobase.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:47713, CHEBI:31310
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C9H11BrN2O5
Net Charge 0
Average Mass 307.09800
Monoisotopic Mass 305.98513
InChI InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
SMILES OC[C@H]1O[C@H](C[C@@H]1O)n1cc(Br)c(=O)[nH]c1=O
Roles Classification
Biological Role(s): antimetabolite
A substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing 5-bromo-2'-deoxyuridine (CHEBI:472552) has role antimetabolite (CHEBI:35221)
5-bromo-2'-deoxyuridine (CHEBI:472552) has role antineoplastic agent (CHEBI:35610)
5-bromo-2'-deoxyuridine (CHEBI:472552) is a pyrimidine 2'-deoxyribonucleoside (CHEBI:19255)
INNs Sources
broxuridina ChemIDplus
broxuridine ChemIDplus
broxuridinum ChemIDplus
Synonyms Sources
5-Bdu ChemIDplus
5-Bromodeoxyuridine ChemIDplus
5-Bromodesoxyuridine ChemIDplus
5-Bromouracil deoxyriboside ChemIDplus
5-Bromouracil-2-deoxyriboside ChemIDplus
Bromodeoxyuridine ChemIDplus
Bromouracil deoxyriboside ChemIDplus
Manual Xrefs Databases
3042 DrugCentral
Bromodeoxyuridine Wikipedia
U33 PDBeChem
View more database links
Registry Numbers Types Sources
4236087 Beilstein Registry Number Beilstein
59-14-3 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
17325220 PubMed citation ChEMBL
17341060 PubMed citation ChEMBL
3950402 PubMed citation Europe PMC
Last Modified
06 March 2017